Forty Seven Inc.

2 articles about Forty Seven Inc.

• 

  It's All MDS and AML Trials Go for Gilead as FDA Lifts Partial Hold

  4/12/2022

  The FDA's decision to lift the hold directive on April 11 involving the investigational drug magrolimab follows a comprehensive review of each trial's safety data. 

• Forty Seven Receives $5M Grant From The CIRM to Support Ongoing Clinical Trial in Acute Myeloid Leukemia

  12/6/2017

  - CIRM grant will support further development of Forty Seven Inc.'s CD47 antibody Hu5F9-G4 in an ongoing second trial for the treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome -   [06-December-2017]   MENLO PARK, Calif., Dec. 6, 2017 /PRNewswire/ -- Forty Seven Inc., a clinical-stage company focused on developing the next generation of transformati